Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/07/2022 08:30 EST Earnings Call Q1 2023 -- -- --
10/06/2022 -- Results Q1 2023 -- -0.07 --
07/28/2022 08:30 EST Earnings Call Q4 2022 -- -- --
07/27/2022 -- Results Q4 2022 -0.07 -0.08 14.88%
04/06/2022 -- Results Q3 2022 0.07 -0.08 193.8%
04/06/2022 08:30 EST Earnings Call Q3 2022 -- -- --
01/10/2022 -- Results Q2 2022 -- -0.08 --
01/10/2022 08:30 EST Earnings Call Q2 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/06/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/27/2022
Beat/Miss Upgrade
Return Since -11.96%
Last FQE 05/31/2022
Next FQE 08/31/2022

Profile

Edit
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Oct. 06, 2022
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
-75.72%
-51.78%
-14.89%
-59.18%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.90%
--
--
--
--
--
-84.27%
22.13%
-61.78%
-43.68%
-9.16%
142.8%
7.63%
8.27%
-43.27%
-73.72%
-89.41%
-32.14%
-14.98%
115.7%
50.55%
197.1%
-31.74%
65.37%
-67.64%
-44.04%
-68.72%
-60.09%
-83.95%
-24.91%
3.66%
32.47%
-80.46%
As of October 03, 2022.

Profile

Edit
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Oct. 06, 2022
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
HMMJ.TO 17.40M USD 11.50%
MJJ 4.845M USD 9.90%
POTX 3.527M USD 7.19%
MJ 22.56M USD 6.74%
CNBS 2.464M USD 6.61%
YOLO 3.343M USD 5.60%
AMRHX 10264.00 USD 3.47%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter TLRY Tweets